Search
Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (formaldehyde inactivated)
go.drugbank.com/drugs/DB15788ApprovedInvestigationalWithdrawnA seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. … Inactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde 3.
Synonyms: Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (formaldehyde inactivated)Solcoseryl
go.drugbank.com/drugs/DB15794InvestigationalMixtures: SOLCOSERYL ADHEZIV DIS PATI, 5 GProducts: SOLCOSERYL JELLY 2 g/20 g, SOLCOSERYL OINTMENT 1 g/20 gGC-373
go.drugbank.com/drugs/DB15797ExperimentalGC-373 is a peptide aldehyde which is metabolized from the bisulfide adduct, [GC-376 free acid][A219031,A219036]. … It is an inhibitor of M<sup>pro</sup> (otherwise known as 3CL<sup>pro</sup>), a viral encoded protease that cleaves and activates functional proteins involved in viral replication and transcription[A219036
Categories: Heterocyclic Compounds, 1-RingMycobacterium w. Vaccine
go.drugbank.com/drugs/DB15798InvestigationalThe Mycobacterium w (M.w) vaccine is a heat-killed suspension derived from a non-pathogenic mycobacterium: mycobacterium indicus pranii. … As an immunotherapy, M.w is used against leprosy; the compound also shares antigens with M. tuberculosis.
Synonyms: Mycobacterium W Vaccine, Mycobacterium w. VaccineVA-MENGOC-BC®
go.drugbank.com/drugs/DB15800ExperimentalVA-MENGOC-BC is a meningococcal B and C vaccine and an outer membrane vesicle (OMV)-based vaccine. … As there already exists a polysaccharide-based vaccine against meningococcal disease originating from serogroups A,C,W135, and Y, this vaccine was created for use against serogroups B and C.
Synonyms: Meningococcal polysaccharide vaccine groups B and CCIGB 2020 Vaccine
go.drugbank.com/drugs/DB15808ExperimentalAs of July, 2020, a Randomized control clinical trial (RPCEC00000306) is underway to evaluate prophylaxis potential in suspected contacts of Covid-19 patients. … CIGB 2020 is a vaccine candidate administered nasally and sublingually, working to strengthen immunity in the areas administered.
BacTRL-spike
go.drugbank.com/drugs/DB15811InvestigationalAs of June, 2020, the company is pursuing a Phase 1, Randomized, Observer-Blind, Placebo-Controlled Trial (NCT04334980) to test the safety and immunogenicity of the vaccine. … BacTRL-Spike is composed of a bacterial medium with colony-forming-units of live Bifidobacterium longum engineered to deliver synthetic DNA encoding spike protein from SARS-CoV-2 contained by plasmids.
Boldo leaf extract
go.drugbank.com/drugs/DB15815ApprovedWithdrawnBoldo leaf extract allergenic extract is used in allergenic testing.
Potassium aspartate
go.drugbank.com/drugs/DB15819ApprovedWithdrawnMixtures: TROMCARDİN 0,5 G + 0,5 G/10 ML IV ENJEKSİYONLUK ÇÖZELTİ (5 AMPUL), C-1000 Plus Zinc & PotassiumSynonyms: L-aspartate potassium